EUVIMEDEUVIMED entdecken
Crossref

Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn’s disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years

Byong Duk Ye, Ken Sugimoto, Jae Hee Cheon, Christopher Gasink, Yuya Imai, Bryan Wahking, Jianmin Zhuo, Shiho Kawamura, Toshifumi Hibi

Intestinal Research · 10.07.2026

DOI: 10.5217/ir.2025.00285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Intestinal Research, online erschienen am 10.07.2026. Verfasst von Byong Duk Ye und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AsianCrohn diseasePatientsUstekinumab

Autor:innen und Institutionen

  • Department of Gastroenterology, Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Internal Medicine 1 (Divisions of Gastroenterology, Nephrology & Neurology), Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Johnson & Johnson Scientific Affairs, LLC, Horsham, PA, USA.
  • Johnson & Johnson K.K. Japan, Tokyo, Japan.
  • Johnson & Johnson Asia Pacific, Singapore.

Zitieren

APA

Ye, B. D., Sugimoto, K., Cheon, J. H., Gasink, C., Imai, Y., Wahking, B., Zhuo, J., Kawamura, S., & Hibi, T. (2026). Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn’s disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years. Intestinal Research. https://doi.org/10.5217/ir.2025.00285

Vancouver

Ye BD, Sugimoto K, Cheon JH, Gasink C, Imai Y, Wahking B, et al. Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn’s disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years. Intestinal Research. 2026. doi:10.5217/ir.2025.00285

BibTeX
@article{Ye2026,
  author = {Ye, Byong Duk and Sugimoto, Ken and Cheon, Jae Hee and Gasink, Christopher and Imai, Yuya and Wahking, Bryan and Zhuo, Jianmin and Kawamura, Shiho and Hibi, Toshifumi},
  title = {Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn’s disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years},
  journal = {Intestinal Research},
  year = {2026},
  doi = {10.5217/ir.2025.00285}
}
Kostenlos starten →